Property, Plant, and Equipment: The sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
CRISPR Therapeutics AG (CRSP) had Property, Plant, and Equipment of $112.17M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.46M |
|
$-122.93M |
|
-- |
|
$1.46M |
|
$131.71M |
|
$-130.25M |
|
$8.16M |
|
$-122.09M |
|
$-122.09M |
|
$-122.93M |
|
$-122.93M |
|
$-122.93M |
|
$-122.93M |
|
$-130.25M |
|
$-125.93M |
|
96.05M |
|
96.05M |
|
$-1.28 |
|
$-1.28 |
|
| Balance Sheet Financials | |
$2.45B |
|
|
Property, Plant, and Equipment |
$112.17M |
$277.46M |
|
$2.73B |
|
$136.29M |
|
$585.47M |
|
$774.98M |
|
$911.26M |
|
$1.81B |
|
$1.81B |
|
$1.81B |
|
96.39M |
|
| Cash Flow Statement Financials | |
$-108.90M |
|
$-410.74M |
|
$591.91M |
|
$359.08M |
|
$431.31M |
|
$72.24M |
|
$16.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.96 |
|
-- |
|
-- |
|
0.24 |
|
0.32 |
|
100.00% |
|
-8933.33% |
|
-8933.33% |
|
-- |
|
-8373.94% |
|
-8431.48% |
|
$-109.40M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-6.77% |
|
-6.77% |
|
-4.51% |
|
-5.12% |
|
$18.83 |
|
$-1.14 |
|
$-1.13 |
|